Objective:

To explore effective strategies for managing postoperative inflammation in cataract surgery, emphasizing their critical role in enhancing patient recovery and comfort.

Key Findings:

• Corticosteroids and NSAIDs are crucial for managing postoperative inflammation, significantly impacting recovery.
• Topical medication adherence is low, with rates between 30% to 80%, highlighting the need for alternative strategies.
• Intracameral and sustained-release medications can significantly reduce the need for postoperative drops, improving patient compliance.
• Glaucoma patients can safely use intracanalicular dexamethasone without increased IOP risk, ensuring effective inflammation management.

Interpretation:

The shift towards intraoperative and sustained-release medications represents a significant advancement in managing postoperative inflammation, enhancing patient experience, compliance, and overall recovery outcomes.

Limitations:

• Further evidence is needed to fully validate the efficacy of intracameral NSAIDs compared to topical NSAIDs, which may affect treatment choices.
• The study does not address long-term outcomes of sustained-release medications, which is crucial for comprehensive patient care.

Conclusion:

Adopting dropless strategies can simplify postoperative care, improve adherence, and potentially enhance recovery outcomes for cataract surgery patients, ultimately leading to better patient satisfaction.